OUR LATEST
news
How Seo Solution helped Kuste Biopharma expand its audience
At first, I thought that promoting our company on the Internet was a dry and dull routine, but the guys from Seo Solution changed my mind.
When SEO surprises
Most SEO agencies are empty promises. Seo Solution acts differently: they are fully involved in the process. They do not just lay out a plan, but weave it with our vision. They discuss real issues and requests of our target audience.
By the way, our acquaintance began with this text: https://seosolution.ua/prodvizhenie-sajta-france.html
What really worked
This cooperation showed us specific improvements that can be measured by numbers and processes. In a few months, we saw how the indicators were changing. For those interested, we decided to collect the main factors of improvements:
- Growth of organic traffic on key pages by more than 40%.
- Reduction in the cost of a lead due to more accurate targeting.
- The emergence of stable positions for medical queries in the French segment.
- Improving conversion from the site after optimizing the structure.
This is not an abstract list, but real achievements that we see right now. That is why Seo Solution is a strategic partner for us.
Kuste Biopharma
At KUSTE we focus on two therapeutics areas
Bladder Pain Syndrome/IC
Kuste develops therapies for unmet medical inflammatory urological diseases such as Bladder Pain Syndrome/Interstitial Cystitis
Inflammatory Bowel Diseases
KUSTE prioritises areas of GI associated with high unmet need, such as inflammatory bowel disease.
Development
Two small peptides acting in the JNK inhibition, have reached up to Phase 3 results.
We are always Focused on
KEY FIGURES
Proprietary molecules
10+ years extensively studied, proven safe and efficacious JNK inhibitors for a variety of therapeutic applications.
JNK INHIBITION
Inhibitors of the JNK pathway have a proven therapeutic impact in the treatment of inflammatory diseases.
Launching studies
Launching clinical studies for the unmet clinical need of BPS/IC and preclinical on other inflammatory pathologies e.g. IBD
Discover the team
Governance
Read more about our Scientific Advisory Board and Management Team…
